0.0495USD-4.62%Mkt Cap: —P/E: —2d ago
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, wh…
Industry Peers
Financial ServicesKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.28M $
Revenue/Share—
Last Price0.0495 USD
Fiscal Year End—
MR Quarter—
Employees18
CountryUS
SectorFinancial Services
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.01
EPS (TTM)—
EPS (Forward)—
52W Range
0.033968% of range0.0570
52W High0.0570 USD
52W Low0.0339 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE319.08%
ROA-599.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.33M $
CapEx (TTM)64.44K $
FCF Margin—
FCF Yield—
Net Debt8.78M $
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity-0.91
Current Ratio0.29
Quick Ratio0.12
Book Value/Sh-4.4720 USD
Cash/Share0.1650 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float1.07M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.20
S&P 52W Chg18.16%
Avg Vol (30d)49.20K
Avg Vol (10d)—
Technical Indicators
RSI (14)69.0
MACD0.0050
MACD Signal0.0039
MACD Hist.+0.0011
BB Upper0.0617 USD
BB Middle0.0418 USD
BB Lower0.0218 USD
BB Width95.60%
ATR (14)0.0044 USD
Vol Ratio (20d)0.18x